HEATHER BIENZ: Open Payments
NPI 1750123873 · CICERO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,458 in 129 payments from 31 companies in 2025. Trend: 2023 $0 · 2024 $840 · 2025 $2,458
Food & beverage: $2,458
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $324 |
| Otsuka America Pharmaceutical, Inc. | 9 | $237 |
| ABBVIE INC. | 14 | $228 |
| Madrigal Pharmaceuticals | 3 | $217 |
| AstraZeneca Pharmaceuticals LP | 9 | $195 |
| Lilly USA, LLC | 13 | $177 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $169 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $123 |
| PFIZER INC. | 6 | $95 |
| Exact Sciences Corporation | 4 | $71 |
Products named: REXULTI, REZDIFFRA, Kerendia, Ozempic, Rybelsus, CAPLYTA, QULIPTA, FARXIGA.
Industry payments across NY — which companies pay providers there.
